Breast Cancer
Conditions
Interventions
Neoadjuvant Group:NA
Adjuvant Group:NA
Sponsors
First Affiliated Hospital, Xi’an Jiaotong University
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Breast cancer patients aged 18 and above with TNM stage 0-III, pathologically confirmed as having primary ductal carcinoma, lobular carcinoma, neuroendocrine carcinoma, metaplastic breast carcinoma, etc., who have received neoadjuvant chemotherapy, neoadjuvant chemotherapy combined with targeted and immunotherapy, as well as postoperative chemotherapy, targeted therapy, and immunotherapy.
Exclusion criteria
Exclusion criteria: 1.Stage IV (metastatic) breast cancer. 2.Patients unable to complete standard treatment for various reasons. 3.Criteria for termination or withdrawal of study subjects. 4.Termination of the study due to cessation of cooperation or follow-up by the research center.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pCR rate;Cancer-related death;Total death rate;Other causes death rate;Event free survival rate;Local recurrence;Distant metastasis rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Breast cancer specific survival, BCSS;Overall survival, OS;Diease free survival, DFS; | — |
Countries
China
Contacts
Public ContactCan Zhou
Breast Surgery Department, First Affiliated Hospital, Xi’an Jiaotong University
Outcome results
None listed